Israel vs Micronesia (country): Number of people diagnosed with new episode of pulmonary TB who are
Israel
33
in 2021
Micronesia (country)
36
in 2021
Israel rank
138th
Micronesia (country) rank
136th
Number of people diagnosed with new episode of pulmonary TB who are over time
- Israel
- Micronesia (country)
How they compare
Micronesia (country) currently reports 36 against 33 in Israel, a difference of 3.
That makes Micronesia (country)'s figure about 1.1 times Israel's.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Israel ahead.
Israel ranks 138th and Micronesia (country) ranks 136th of 214 countries.
Across the 3 decades both report, Israel averaged higher in 2 and Micronesia (country) in 1.
Head to head by decade
| Decade | Israel | Micronesia (country) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 180 | 58.6 | 121.4 | Israel |
| 2010s | 99.2 | 70.1 | 29.1 | Israel |
| 2020s | 28 | 45 | 17 | Micronesia (country) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people diagnosed with new episode of pulmonary tb who are, Israel or Micronesia (country)?
- Micronesia (country), at 36 against 33 in Israel as of 2021.
- What is the difference in number of people diagnosed with new episode of pulmonary tb who are between Israel and Micronesia (country)?
- 3, with Micronesia (country) ahead.
- How many years of comparable data are there for Israel and Micronesia (country)?
- 22 years are reported by both, from 2000 to 2021.
- How do Israel and Micronesia (country) rank globally for number of people diagnosed with new episode of pulmonary tb who are?
- Israel ranks 138th and Micronesia (country) ranks 136th of 214 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of people diagnosed with new episode of pulmonary TB who are clinically diagnosed.. Statizoid refreshes it automatically from the source and publishes the full history for both places.